Dear Editor, By identifying H1N1 infection as a new risk factor for the development of invasive pulmonary aspergillosis (IPA), Wauters et al. [1] contribute important new insights into this emerging problem.
Although we totally agree with their conclusion, we question the high incidence of IPA in their study (23 %) and the rapid onset of IPA after H1N1 infection. Regarding this point we have two concerns. First, in the proven IPA group, the diagnosis of IPA was made before or on the day of ICU admission in three of the five patients. All of them were solid organ transplant recipients and therefore had classic risk factors for IPA. According to Table 2 and the ''Methods'' section, the diagnosis of proven IPA was established around or even before the diagnosis of H1N1 infection. Therefore IPA can hardly be assumed to be a complication of H1N1 infection in these patients. Second, despite the finding of positive galactomannan antigen from BAL and/or serum, we suppose that some of the cases of probable IPA were simply colonization. As the authors discussed, in larger prospective studies the incidence of fungal superinfections was considerably lower at 1.6 and 1.8 % [2, 3] . To understand this wide difference it would be useful to know if there were any lower respiratory tract samples positive for Aspergillus spp. in the remaining 31 patients classified as ''No IPA''.
